There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series, Dr. Jonathan C. Roberts and Dr. Mindy Simpson inform and guide on safely integrating recently approved agents into the treatment continuum while ensuring alignment with critical new breakthroughs and enabling patient-focused care pathways.
Launch Date: February 4, 2025
Release Date: February 4, 2025
Expiration Date: January 31, 2026
FACULTY
Jonathan C. Roberts, MD
Associate Medical Director
Associate Research Director
Bleeding and Clotting Disorders Institute
Associate Professor of Pediatrics and Medicine
University of Illinois College of Medicine at Peoria
Mindy Simpson, MD
Medical Director
Rush Hemophilia and Thrombophilia Center
Assistant Professor of Pediatrics in Pediatric Hematology/Oncology
Rush University Medical Center
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information here prior to listening to this episode.
Popular Podcasts
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
The Joe Rogan Experience
The official podcast of comedian Joe Rogan.
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Special Summer Offer: Exclusively on Apple Podcasts, try our Dateline Premium subscription completely free for one month! With Dateline Premium, you get every episode ad-free plus exclusive bonus content.